Tool overview
TwentyTwo is listed under Cybersecurity AI tools.
What is TwentyTwo?
TwentyTwo built AI infrastructure for biosecurity, helping labs, biotechnology companies, governments, and model developers evaluate biological AI capabilities, interpret sensitive outputs, forecast risk, and apply safeguards. The company was acquired by LatchBio and now contributes to Latch Biosecurity.
Best for
Life-science and AI organizations evaluating biological model risk and safeguards
Who is it for?
Decision note
This row records a confirmed acquisition without changing the tool name or slug. Before any future rename to Latch Biosecurity, the admin must approve the official-name, website, slug, and permanent-redirect plan while preserving the existing Post ID.
Key features
Biological AI capability research
Model behavior and output interpretation
Safeguard and access-control research
Biosecurity forecasting and evaluation
Integration into the Latch Biosecurity division
Use cases
Evaluate biological model capabilities
Assess dual-use research risk
Design safeguards for AI-enabled biology
Forecast emerging biosecurity threats
Support responsible life-science AI deployment
Pros
- Focused on a high-consequence AI safety domain
- Team combines biosecurity and technical expertise
- Works across multiple biological model families
- Acquisition provides a larger life-science platform
Cons
- Standalone TwentyTwo commercial offering is no longer clear
- Biosecurity conclusions require expert and policy review
Limitations
Biosecurity evaluation is inherently uncertain and dual use. Assessments should not replace institutional biosafety, legal, ethics, public-health, model-provider, or government controls. Sensitive details and access must be handled through strict need-to-know procedures.
Pricing details
Billing options
Custom research or security engagement
Pricing note
TwentyTwo publishes no standalone self-service price and has been acquired into LatchBio’s biosecurity division. Pricing Model and Starting Price are Contact sales for any current engagement. No ongoing free plan or public self-service trial was confirmed.
Supported languages
- English
Integrations
LatchBio
Biological model evaluation workflows
Life-science research systems
Please log in to join the discussion.